Eikon Therapeutics Inc (EIKN)

Finanzdaten der Eikon Therapeutics Inc-Aktie (EIKN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
	6.94%93.39	87.34
Research and Development	7.73%75.46	70.05
Operating Income/Loss	6.94%-93.39	-87.34
Net Interest Income/Expense	15.00%5.04	4.38
	6.57%-88.41	-82.96
Attributable To Parent	6.57%-88.41	-82.96
Available To Common Stockholders, Basic	6.57%-88.41	-82.96
Basic Average Shares	60.66%54.14	33.70
Diluted Average Shares	60.66%54.14	33.70
Basic Earnings Per Share	33.74%-1.63	-2.46
Diluted Earnings Per Share	33.74%-1.63	-2.46